Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Stroke

• Publication date

  1991-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.22.8.1075PMID 1866755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia.

  1990cited by this paper
• Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

  1989cited by this paper
• N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia?

  1989cited by this paper
• Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.

  1988cited by this paper
• The Estimation of Solubility in Binary Solvents: Application of the Reduced 3-Suffix Solubility Equation to Ethanol–Water Mixtures

  1988cited by this paper
• Morphinans attenuate cortical neuronal injury induced by glucose deprivation in vitro.

  1988cited by this paper
• Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.

  1987cited by this paper
• The Polymorphic Metabolism of Dextromethorphan

  1987cited by this paper
• Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons.

  1987cited by this paper
• Glutamate and the pathophysiology of hypoxic–ischemic brain damage

  1986cited by this paper

• Analisis Hukum dan Kriminologi terhadap Fenomena Penyalahgunaan Zat Dextromethorphan dalam Obat Batuk di Manado

  2023cites this paper
• Cerebroprotection for Acute Ischemic Stroke

  2021cites this paper
• Patent Application Publication Nov . 5 , 2015 Sheet 2 of 3 US 2015 / 0313892 A 1 CO 2 H CO 2 H NH NH 2 2 Gabapentin Pregabalin

  2017cites this paper
• Intraoperative Cerebral Protection

  2011cites this paper
• Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic stroke

  2011cites this paper
• Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.

  2011cites this paper
• Farmacología de la neuroprotección en el ictus isquémico agudo

  2008cites this paper
• [Pharmacology of neuroprotection in acute ischemic stroke].

  2008cites this paper
• Dextromethorphan is protective against sensitized N‐methyl‐d‐aspartate receptor‐mediated excitotoxic brain damage in the developing mouse brain

  2008cites this paper
• Dextromethorphan as a Potential Neuroprotective Agent With Unique Mechanisms of Action

  2007cites this paper
• Association Scientific Statement From the Stroke Council of the American Stroke Guidelines for the Early Management of Patients With Ischemic Stroke: A

  2007cites this paper
• Effect of Dextromethorphan on Reference Memory Assessed in Rats by a Three-panel Runway Task

  2006cites this paper
• Dextromethorphan, 3-methoxymorphinan, and dextrorphan have local anaesthetic effect on sciatic nerve blockade in rats.

  2006cites this paper
• Comments, Opinions, and Reviews Prophylactic Neuroprotection for Cerebral Ischemia

  2005cites this paper
• Retinal ischemia: mechanisms of damage and potential therapeutic strategies.

  2004cites this paper
• Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association

  2003cites this paper
• Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats.

  2001cites this paper
• Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.

  2001cites this paper
• Review Articl e The role of dextromethorphan i n pain contro l

  2000cites this paper
• The role of dextromethorphan in pain control

  2000cites this paper
• Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications.

  2000cites this paper
• Dextromethorphan in chronic pain: a disappointing update.

  2000cites this paper
• Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions.

  2000cites this paper
• Neuroprotective Effects of Magnesium Sulfate and Dextromethorphan on Cerebral Ischemia after Middle Cerebral Artery Occlusion in Rats.

  1999cites this paper
• Neuronal death after brain injury

  1999cites this paper
• The pursuit of effective neuroprotection during infant cardiac surgery.

  1999cites this paper
• Limiting Neurological Damage After Stroke

  1999cites this paper
• Dextromethorphan attenuates ethanol withdrawal syndrome in rats.

  1999cites this paper
• Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo.

  1999cites this paper
• A phase I clinical trial of dextromethorphan in intractable partial epilepsy.

  1999cites this paper
• Dextromethorphan and pain after total abdominal hysterectomy.

  1998cites this paper
• Monotherapy with dextromethorphan or tirilazad – but not a combination of both – improves outcome after transient focal cerebral ischemia in rats

  1998cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• Pharmacological Advances in Cerebrovascular Protection

  1998cites this paper
• Dose Escalation Safety and Tolerance Study of the Competitive NMDA Antagonist Selfotel (CGS 19755) in Neurosurgery Patients

  1998cites this paper
• A review of earlier clinical studies on neuroprotective agents and current approaches.

  1997cites this paper
• Acute ischemic stroke therapy. A clinical overview.

  1997cites this paper
• Dextromethorphan reduces intravenous cocaine self-administration in the rat.

  1997cites this paper
• Hypoxic-ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection.

  1997cites this paper
• Intraoperative Pharmacologic Brain Protection

  1997cites this paper
• Considerations in the design of clinical trials of neuroprotective therapy in acute stroke.

  1996cites this paper
• Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients.

  1996cites this paper
• Medical therapy for ischemic stroke.

  1996cites this paper
• Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

  1996cites this paper
• Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret.

  1996cites this paper
• Recently Developed Neuroprotective Therapies for Acute Stroke

  1996cites this paper
• Protection cérébrale médicamenteuse : agents spécifiques

  1995cites this paper
• [The glutaminergic system (II): the physiopathological, clinical and therapeutic aspects].

  1995cites this paper
• N-Methyl-D-Aspartate (NMDA) Receptors, Mu and Kappa Opioid Tolerance, and Perspectives on New Analgesic Drug Development

  1995cites this paper
• [Pharmacologic brain protection: specific agents].

  1995cites this paper
• CHAPTER 32 – An Overview of Cytoprotective Therapy for Acute Ischemic Stroke

  1995cites this paper
• Neuroprotective effects of dextromethorphan against transient cerebral ischemia/reperfusion injury in gerbils.

  1995cites this paper
• Section Review Central & Peripheral Nervous Systems Pharmacological modulation of opioid tolerance

  1995cites this paper
• The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal

  1995cites this paper
• Taxonomy and Mechanisms of Neuropathic Pain

  1994cites this paper
• Antagonists of Excitatory Amino Acid Receptors in the Treatment of Parkinson’s Disease

  1994cites this paper
• Prophylactic Neuroprotection for Cerebral Ischemia

  1994cites this paper
• Dextromethorphan attenuates and reverses analgesic tolerance to morphine

  1994cites this paper
• Combination Therapy Protects Ischemic Brain in Rats: A Glutamate Antagonist Plus a γ‐Aminobutyric Acid Agonist

  1994cites this paper
• Exciting your neurons to death: can we prevent cell loss after brain injury?

  1994cites this paper
• Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit.

  1994cites this paper
• A review of brain retraction and recommendations for minimizing intraoperative brain injury.

  1993cites this paper
• Tolerability of oral dextromethorphan in patients with a history of brain ischemia.

  1992cites this paper